Eris Lifesciences Appoints Akhil Awasthi as Additional Director

Eris Lifesciences Ltd has announced the appointment of Mr. Akhil Awasthi as an Additional Director (Non-executive, Independent) to its Board of Directors. The appointment, approved via a circular resolution dated September 21, 2026, is effective from September 26, 2026, for a term of five years, subject to shareholder approval. Mr. Awasthi brings over three decades of experience in private equity, investment management, healthcare, and corporate governance, having held senior roles at Tata Capital Growth Fund and Baring Private Equity Partners (India) Ltd. He is not related to any existing director and is not debarred from holding a directorship.